25 XP   0   0   10

NeuroMetrix Inc
Buy, Hold or Sell?

Let's analyse Neurometrix together

PenkeI guess you are interested in NeuroMetrix Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of NeuroMetrix Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about NeuroMetrix Inc

I send you an email if I find something interesting about NeuroMetrix Inc.

Quick analysis of Neurometrix (30 sec.)










What can you expect buying and holding a share of Neurometrix? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$10.11
Expected worth in 1 year
$8.47
How sure are you?
42.5%

+ What do you gain per year?

Total Gains per Share
$-1.64
Return On Investment
-37.3%

For what price can you sell your share?

Current Price per Share
$4.41
Expected price per share
$3.51 - $4.96
How sure are you?
50%

1. Valuation of Neurometrix (5 min.)




Live pricePrice per Share (EOD)

$4.41

Intrinsic Value Per Share

$-286.77 - $-15.81

Total Value Per Share

$-276.66 - $-5.69

2. Growth of Neurometrix (5 min.)




Is Neurometrix growing?

Current yearPrevious yearGrowGrow %
How rich?$20m$23.2m-$2.3m-11.4%

How much money is Neurometrix making?

Current yearPrevious yearGrowGrow %
Making money-$1.5m-$1m-$536.9k-33.6%
Net Profit Margin-112.1%-51.6%--

How much money comes from the company's main activities?

3. Financial Health of Neurometrix (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#204 / 334

Most Revenue
#253 / 334

Most Profit
#159 / 334

Most Efficient
#252 / 334

What can you expect buying and holding a share of Neurometrix? (5 min.)

Welcome investor! Neurometrix's management wants to use your money to grow the business. In return you get a share of Neurometrix.

What can you expect buying and holding a share of Neurometrix?

First you should know what it really means to hold a share of Neurometrix. And how you can make/lose money.

Speculation

The Price per Share of Neurometrix is $4.41. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Neurometrix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Neurometrix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $10.11. Based on the TTM, the Book Value Change Per Share is $-0.41 per quarter. Based on the YOY, the Book Value Change Per Share is $2.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Neurometrix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.83-18.8%-0.80-18.2%-0.22-5.0%-0.36-8.1%-1.08-24.5%
Usd Book Value Change Per Share0.092.1%-0.41-9.3%2.0746.9%0.358.0%0.163.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.092.1%-0.41-9.3%2.0746.9%0.358.0%0.163.7%
Usd Price Per Share3.60-1.69-3.03-2.75-2.15-
Price to Earnings Ratio-1.08--0.53--4.29--6.50--3.32-
Price-to-Total Gains Ratio38.08-7.94-16.89-58.11-28.49-
Price to Book Ratio0.36-0.16-0.83-1.07-0.82-
Price-to-Total Gains Ratio38.08-7.94-16.89-58.11-28.49-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.41
Number of shares226
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.410.35
Usd Total Gains Per Share-0.410.35
Gains per Quarter (226 shares)-92.8479.60
Gains per Year (226 shares)-371.37318.40
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-371-3810318308
20-743-7520637626
30-1114-11230955944
40-1485-1494012741262
50-1857-1865015921580
60-2228-2236019101898
70-2600-2607022292216
80-2971-2978025472534
90-3342-3349028662852
100-3714-3720031843170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%4.036.00.010.0%11.070.01.013.4%
Book Value Change Per Share1.03.00.025.0%6.06.00.050.0%8.012.00.040.0%17.023.00.042.5%29.053.00.035.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%1.00.081.01.2%
Total Gains per Share1.03.00.025.0%6.06.00.050.0%8.012.00.040.0%17.023.00.042.5%30.052.00.036.6%

Fundamentals of Neurometrix

About NeuroMetrix Inc

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-11 16:17:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of NeuroMetrix Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Neurometrix earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Neurometrix to the Medical Devices industry mean.
  • A Net Profit Margin of -125.2% means that $-1.25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of NeuroMetrix Inc:

  • The MRQ is -125.2%. The company is making a huge loss. -2
  • The TTM is -112.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-125.2%TTM-112.1%-13.1%
TTM-112.1%YOY-51.6%-60.5%
TTM-112.1%5Y-55.0%-57.1%
5Y-55.0%10Y-75.4%+20.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-125.2%-12.4%-112.8%
TTM-112.1%-20.4%-91.7%
YOY-51.6%-14.4%-37.2%
5Y-55.0%-21.3%-33.7%
10Y-75.4%-25.0%-50.4%
1.1.2. Return on Assets

Shows how efficient Neurometrix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Neurometrix to the Medical Devices industry mean.
  • -7.7% Return on Assets means that Neurometrix generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of NeuroMetrix Inc:

  • The MRQ is -7.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.7%TTM-7.2%-0.5%
TTM-7.2%YOY-4.3%-3.0%
TTM-7.2%5Y-6.7%-0.5%
5Y-6.7%10Y-13.4%+6.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.7%-4.1%-3.6%
TTM-7.2%-4.7%-2.5%
YOY-4.3%-4.6%+0.3%
5Y-6.7%-4.0%-2.7%
10Y-13.4%-5.2%-8.2%
1.1.3. Return on Equity

Shows how efficient Neurometrix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Neurometrix to the Medical Devices industry mean.
  • -8.2% Return on Equity means Neurometrix generated $-0.08 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of NeuroMetrix Inc:

  • The MRQ is -8.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.2%TTM-7.7%-0.5%
TTM-7.7%YOY-4.6%-3.1%
TTM-7.7%5Y-12.1%+4.4%
5Y-12.1%10Y-25.9%+13.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.2%-4.2%-4.0%
TTM-7.7%-5.8%-1.9%
YOY-4.6%-5.5%+0.9%
5Y-12.1%-6.3%-5.8%
10Y-25.9%-7.1%-18.8%

1.2. Operating Efficiency of NeuroMetrix Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Neurometrix is operating .

  • Measures how much profit Neurometrix makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Neurometrix to the Medical Devices industry mean.
  • An Operating Margin of -140.9% means the company generated $-1.41  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of NeuroMetrix Inc:

  • The MRQ is -140.9%. The company is operating very inefficient. -2
  • The TTM is -125.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-140.9%TTM-125.8%-15.1%
TTM-125.8%YOY-58.1%-67.7%
TTM-125.8%5Y-73.3%-52.5%
5Y-73.3%10Y-112.0%+38.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-140.9%-24.3%-116.6%
TTM-125.8%-16.4%-109.4%
YOY-58.1%-14.0%-44.1%
5Y-73.3%-20.4%-52.9%
10Y-112.0%-24.8%-87.2%
1.2.2. Operating Ratio

Measures how efficient Neurometrix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 2.41 means that the operating costs are $2.41 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of NeuroMetrix Inc:

  • The MRQ is 2.409. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.253. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.409TTM2.253+0.157
TTM2.253YOY1.579+0.673
TTM2.2535Y1.729+0.524
5Y1.72910Y2.015-0.287
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4091.456+0.953
TTM2.2531.439+0.814
YOY1.5791.431+0.148
5Y1.7291.436+0.293
10Y2.0151.374+0.641

1.3. Liquidity of NeuroMetrix Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Neurometrix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 16.81 means the company has $16.81 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of NeuroMetrix Inc:

  • The MRQ is 16.809. The company is very able to pay all its short-term debts. +2
  • The TTM is 16.988. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ16.809TTM16.988-0.179
TTM16.988YOY16.226+0.763
TTM16.9885Y9.678+7.311
5Y9.67810Y6.564+3.114
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ16.8092.693+14.116
TTM16.9882.697+14.291
YOY16.2263.504+12.722
5Y9.6783.617+6.061
10Y6.5643.499+3.065
1.3.2. Quick Ratio

Measures if Neurometrix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Neurometrix to the Medical Devices industry mean.
  • A Quick Ratio of 28.03 means the company can pay off $28.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of NeuroMetrix Inc:

  • The MRQ is 28.035. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 26.846. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ28.035TTM26.846+1.188
TTM26.846YOY24.216+2.630
TTM26.8465Y12.836+14.010
5Y12.83610Y7.815+5.022
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ28.0351.516+26.519
TTM26.8461.658+25.188
YOY24.2162.142+22.074
5Y12.8362.307+10.529
10Y7.8152.370+5.445

1.4. Solvency of NeuroMetrix Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Neurometrix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Neurometrix to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.06 means that Neurometrix assets are financed with 6.2% credit (debt) and the remaining percentage (100% - 6.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of NeuroMetrix Inc:

  • The MRQ is 0.062. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.064. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.062TTM0.064-0.001
TTM0.064YOY0.072-0.009
TTM0.0645Y0.251-0.187
5Y0.25110Y0.330-0.079
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0620.402-0.340
TTM0.0640.389-0.325
YOY0.0720.335-0.263
5Y0.2510.442-0.191
10Y0.3300.461-0.131
1.4.2. Debt to Equity Ratio

Measures if Neurometrix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Neurometrix to the Medical Devices industry mean.
  • A Debt to Equity ratio of 6.6% means that company has $0.07 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of NeuroMetrix Inc:

  • The MRQ is 0.066. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.068. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.066TTM0.068-0.002
TTM0.068YOY0.078-0.010
TTM0.0685Y0.478-0.410
5Y0.47810Y0.692-0.213
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0660.559-0.493
TTM0.0680.560-0.492
YOY0.0780.479-0.401
5Y0.4780.614-0.136
10Y0.6920.674+0.018

2. Market Valuation of NeuroMetrix Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Neurometrix generates.

  • Above 15 is considered overpriced but always compare Neurometrix to the Medical Devices industry mean.
  • A PE ratio of -1.08 means the investor is paying $-1.08 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of NeuroMetrix Inc:

  • The EOD is -1.328. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.084. Based on the earnings, the company is expensive. -2
  • The TTM is -0.527. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.328MRQ-1.084-0.244
MRQ-1.084TTM-0.527-0.557
TTM-0.527YOY-4.290+3.763
TTM-0.5275Y-6.498+5.972
5Y-6.49810Y-3.323-3.175
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.328-1.021-0.307
MRQ-1.084-1.704+0.620
TTM-0.527-2.081+1.554
YOY-4.290-2.980-1.310
5Y-6.498-2.379-4.119
10Y-3.323-1.726-1.597
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of NeuroMetrix Inc:

  • The EOD is -1.464. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.195. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.585. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.464MRQ-1.195-0.269
MRQ-1.195TTM-0.585-0.610
TTM-0.585YOY-4.979+4.394
TTM-0.5855Y-7.088+6.503
5Y-7.08810Y-3.604-3.484
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.464-0.981-0.483
MRQ-1.195-1.578+0.383
TTM-0.585-2.973+2.388
YOY-4.979-6.179+1.200
5Y-7.088-4.928-2.160
10Y-3.604-5.060+1.456
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Neurometrix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.36 means the investor is paying $0.36 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of NeuroMetrix Inc:

  • The EOD is 0.436. Based on the equity, the company is cheap. +2
  • The MRQ is 0.356. Based on the equity, the company is cheap. +2
  • The TTM is 0.163. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.436MRQ0.356+0.080
MRQ0.356TTM0.163+0.193
TTM0.163YOY0.826-0.663
TTM0.1635Y1.070-0.907
5Y1.07010Y0.816+0.254
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.4361.930-1.494
MRQ0.3562.372-2.016
TTM0.1632.444-2.281
YOY0.8263.205-2.379
5Y1.0703.893-2.823
10Y0.8164.245-3.429
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of NeuroMetrix Inc.

3.1. Institutions holding NeuroMetrix Inc

Institutions are holding 5.683% of the shares of NeuroMetrix Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31HPM Partners LLC1.51020.000430000300000
2023-09-30Citadel Advisors Llc0.177028122281220
2023-12-31Renaissance Technologies Corp1.17950.00012343219674523.5232
2023-12-31Vanguard Group Inc0.7613015124151240
2023-12-31Virtu Financial LLC0.60950.003412107121070
2023-12-31Advisor Group Holdings, Inc.0.3410677562751255
2023-12-31BlackRock Inc0.255305071-3-0.0591
2023-12-31Tower Research Capital LLC0.05220.00011037550112.9363
2023-12-31Accent Capital Management LLC0.03150.00186256250
2023-12-31TUCKER ASSET MANAGEMENT LLC0.02020.00044024020
2023-09-30Sutton Wealth Advisors Inc0.0020.000132000
2023-12-31UBS Group AG0.005701141140
2023-12-31Stephens Consulting LLC0.00310.00016200
2023-12-31Advisory Services Network, LLC0.0006012120
2023-12-31Wells Fargo & Co0.00040800
2023-12-31State Street Corporation000-2271-100
2023-12-31Northern Trust Corp000-1382-100
2023-12-31Geode Capital Management, LLC000-8094-100
2023-12-31Northwestern Mutual Wealth Management Co000-50-100
2023-09-30HRT FINANCIAL LLC000-26550-100
Total 4.94950.0064123211+74655+60.6%

3.2. Funds holding NeuroMetrix Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.76130.00011512400
2024-02-29Fidelity Extended Market Index0.23110.0001459000
2024-02-29Fidelity Total Market Index0.0940186700
2024-02-29Fidelity Series Total Market Index0.0483095900
2023-12-31Northern Trust Extended Eq Market Idx0.03960.000178600
2023-12-31NT Ext Equity Mkt Idx Fd - L0.03960.000178600
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0301059700
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0241047910.2092
2023-09-30BlackRock Extended Mkt Composite0.0029046700
2024-02-29Spartan Total Market Index Pool E0.0173034400
2024-02-29Fidelity Nasdaq Composite Index0.0167033200
2023-12-31SSgA U.S. Extended Market Index Class I0.0151030000
2024-03-31State St US Extended Mkt Indx NL Cl C0.01510.000130000
2024-02-29State St US Ttl Mkt Indx SL Cl I0.0056011200
2023-12-31SSgA U.S. Total Market Index Strategy0.0044087-2-2.2472
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00101900
Total 1.34620.000527149-10.0%

3.3. Insider Transactions

Insiders are holding 15.939% of the shares of NeuroMetrix Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-08-25Thomas T HigginsSELL625084.4
2021-08-12Thomas T HigginsSELL2500108.48
2021-06-10Topline Capital Management, LlBUY352927.36

4. Summary

4.1. Key Performance Indicators

The key performance indicators of NeuroMetrix Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.095-0.411+535%2.070-95%0.352-73%0.162-42%
Book Value Per Share--10.11410.498-4%5.435+86%4.520+124%4.050+150%
Current Ratio--16.80916.988-1%16.226+4%9.678+74%6.564+156%
Debt To Asset Ratio--0.0620.064-2%0.072-14%0.251-75%0.330-81%
Debt To Equity Ratio--0.0660.068-2%0.078-15%0.478-86%0.692-90%
Dividend Per Share----0%-0%-0%-0%
Eps---0.830-0.805-3%-0.220-73%-0.359-57%-1.078+30%
Free Cash Flow Per Share---0.753-0.789+5%-0.325-57%-0.376-50%-8.253+996%
Free Cash Flow To Equity Per Share--0.064-0.496+870%0.056+16%0.068-5%-3.798+5994%
Gross Profit Margin--1.5221.5270%1.719-11%1.855-18%1.531-1%
Intrinsic Value_10Y_max---15.807--------
Intrinsic Value_10Y_min---286.773--------
Intrinsic Value_1Y_max---1.620--------
Intrinsic Value_1Y_min---32.495--------
Intrinsic Value_3Y_max---4.839--------
Intrinsic Value_3Y_min---94.957--------
Intrinsic Value_5Y_max---8.026--------
Intrinsic Value_5Y_min---154.007--------
Market Cap8760641.400+18%7151544.0003357699.572+113%19257984.375-63%12459899.196-43%7777439.426-8%
Net Profit Margin---1.252-1.121-10%-0.516-59%-0.550-56%-0.754-40%
Operating Margin---1.409-1.258-11%-0.581-59%-0.733-48%-1.120-21%
Operating Ratio--2.4092.253+7%1.579+53%1.729+39%2.015+20%
Pb Ratio0.436+18%0.3560.163+119%0.826-57%1.070-67%0.816-56%
Pe Ratio-1.328-23%-1.084-0.527-51%-4.290+296%-6.498+500%-3.323+207%
Price Per Share4.410+18%3.6001.690+113%3.030+19%2.752+31%2.155+67%
Price To Free Cash Flow Ratio-1.464-23%-1.195-0.585-51%-4.979+317%-7.088+493%-3.604+202%
Price To Total Gains Ratio46.654+18%38.0847.937+380%16.887+126%58.109-34%28.495+34%
Quick Ratio--28.03526.846+4%24.216+16%12.836+118%7.815+259%
Return On Assets---0.077-0.072-6%-0.043-45%-0.067-13%-0.134+74%
Return On Equity---0.082-0.077-6%-0.046-44%-0.121+47%-0.259+216%
Total Gains Per Share--0.095-0.411+535%2.070-95%0.352-73%0.162-42%
Usd Book Value--20091317.00020854758.000-4%23242608.500-14%13785276.500+46%10448806.125+92%
Usd Book Value Change Per Share--0.095-0.411+535%2.070-95%0.352-73%0.162-42%
Usd Book Value Per Share--10.11410.498-4%5.435+86%4.520+124%4.050+150%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.830-0.805-3%-0.220-73%-0.359-57%-1.078+30%
Usd Free Cash Flow---1495867.000-1567102.500+5%-1331507.500-11%-976801.700-35%-16510645.325+1004%
Usd Free Cash Flow Per Share---0.753-0.789+5%-0.325-57%-0.376-50%-8.253+996%
Usd Free Cash Flow To Equity Per Share--0.064-0.496+870%0.056+16%0.068-5%-3.798+5994%
Usd Market Cap8760641.400+18%7151544.0003357699.572+113%19257984.375-63%12459899.196-43%7777439.426-8%
Usd Price Per Share4.410+18%3.6001.690+113%3.030+19%2.752+31%2.155+67%
Usd Profit---1649547.000-1598398.000-3%-1061457.000-36%-939304.300-43%-1587211.375-4%
Usd Revenue--1317746.0001475356.250-11%2064018.250-36%1953074.400-33%2427102.100-46%
Usd Total Gains Per Share--0.095-0.411+535%2.070-95%0.352-73%0.162-42%
 EOD+6 -2MRQTTM+18 -16YOY+11 -235Y+10 -2410Y+19 -15

4.2. Fundamental Score

Let's check the fundamental score of NeuroMetrix Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.328
Price to Book Ratio (EOD)Between0-10.436
Net Profit Margin (MRQ)Greater than0-1.252
Operating Margin (MRQ)Greater than0-1.409
Quick Ratio (MRQ)Greater than128.035
Current Ratio (MRQ)Greater than116.809
Debt to Asset Ratio (MRQ)Less than10.062
Debt to Equity Ratio (MRQ)Less than10.066
Return on Equity (MRQ)Greater than0.15-0.082
Return on Assets (MRQ)Greater than0.05-0.077
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of NeuroMetrix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.199
Ma 20Greater thanMa 503.953
Ma 50Greater thanMa 1003.839
Ma 100Greater thanMa 2003.584
OpenGreater thanClose4.415
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income Tax Expense  -10-126-136126-100-11110



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets21,424
Total Liabilities1,333
Total Stockholder Equity20,091
 As reported
Total Liabilities 1,333
Total Stockholder Equity+ 20,091
Total Assets = 21,424

Assets

Total Assets21,424
Total Current Assets20,854
Long-term Assets570
Total Current Assets
Cash And Cash Equivalents 1,732
Short-term Investments 16,265
Net Receivables 519
Inventory 1,559
Other Current Assets 779
Total Current Assets  (as reported)20,854
Total Current Assets  (calculated)20,854
+/- 0
Long-term Assets
Property Plant Equipment 544
Long-term Assets Other 26
Long-term Assets  (as reported)570
Long-term Assets  (calculated)570
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,241
Long-term Liabilities92
Total Stockholder Equity20,091
Total Current Liabilities
Short-term Debt 148
Accounts payable 216
Other Current Liabilities 877
Total Current Liabilities  (as reported)1,241
Total Current Liabilities  (calculated)1,241
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt92
Long-term Liabilities  (as reported)92
Long-term Liabilities  (calculated)92
+/- 0
Total Stockholder Equity
Common Stock0
Retained Earnings -210,109
Accumulated Other Comprehensive Income 240
Other Stockholders Equity 229,960
Total Stockholder Equity (as reported)20,091
Total Stockholder Equity (calculated)20,091
+/- 0
Other
Capital Stock0
Cash and Short Term Investments 17,997
Common Stock Shares Outstanding 1,525
Liabilities and Stockholders Equity 21,424
Net Debt -1,491
Net Invested Capital 20,091
Net Working Capital 19,614
Property Plant and Equipment Gross 1,280
Short Long Term Debt Total 241



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-31
> Total Assets 
7,053
0
0
0
7,218
17,079
18,367
38,044
37,953
38,543
39,036
40,283
42,897
44,589
47,708
52,592
55,706
54,143
52,672
50,719
56,375
49,500
43,751
36,113
31,378
27,402
26,396
42,773
40,567
36,066
31,271
27,985
23,066
20,296
17,760
16,149
14,221
18,331
15,682
13,200
10,877
8,891
11,449
9,703
10,797
9,456
15,362
13,569
11,402
9,131
16,033
12,929
16,034
12,308
14,578
11,349
8,284
11,089
8,383
8,773
9,599
10,309
11,808
13,038
12,113
13,907
10,814
8,507
6,894
6,206
8,606
8,340
7,995
7,721
10,769
26,294
24,888
26,248
25,257
24,032
24,670
23,610
22,774
21,287
21,424
21,42421,28722,77423,61024,67024,03225,25726,24824,88826,29410,7697,7217,9958,3408,6066,2066,8948,50710,81413,90712,11313,03811,80810,3099,5998,7738,38311,0898,28411,34914,57812,30816,03412,92916,0339,13111,40213,56915,3629,45610,7979,70311,4498,89110,87713,20015,68218,33114,22116,14917,76020,29623,06627,98531,27136,06640,56742,77326,39627,40231,37836,11343,75149,50056,37550,71952,67254,14355,70652,59247,70844,58942,89740,28339,03638,54337,95338,04418,36717,0797,2180007,053
   > Total Current Assets 
0
0
0
0
4,886
14,634
15,866
35,328
25,735
28,805
33,329
37,822
40,316
41,921
44,973
49,798
52,784
51,279
49,821
47,941
42,024
39,521
35,485
32,493
29,642
25,335
24,537
41,010
38,856
34,454
29,768
26,594
21,677
19,012
16,889
15,342
13,495
17,654
15,298
12,871
10,573
8,628
11,215
9,496
10,567
9,256
15,181
13,370
11,090
8,223
14,999
11,969
15,147
11,464
13,779
10,592
7,587
10,464
7,794
8,221
9,103
9,834
11,339
12,572
11,631
11,630
8,849
6,636
5,431
4,878
7,404
7,290
7,090
6,965
10,031
25,560
24,188
25,587
24,627
23,432
24,107
23,086
22,289
20,706
20,854
20,85420,70622,28923,08624,10723,43224,62725,58724,18825,56010,0316,9657,0907,2907,4044,8785,4316,6368,84911,63011,63112,57211,3399,8349,1038,2217,79410,4647,58710,59213,77911,46415,14711,96914,9998,22311,09013,37015,1819,25610,5679,49611,2158,62810,57312,87115,29817,65413,49515,34216,88919,01221,67726,59429,76834,45438,85641,01024,53725,33529,64232,49335,48539,52142,02447,94149,82151,27952,78449,79844,97341,92140,31637,82233,32928,80525,73535,32815,86614,6344,8860000
       Cash And Cash Equivalents 
2,702
0
0
0
1,623
10,900
10,301
30,643
1,936
2,438
2,768
3,304
8,170
5,396
5,162
6,567
7,910
6,816
4,778
6,700
7,097
10,884
13,514
21,592
12,302
5,920
5,465
22,037
22,937
20,793
19,080
18,924
16,987
15,102
13,622
11,715
10,290
15,213
13,325
10,926
8,699
6,886
9,586
7,836
9,196
7,584
13,694
11,687
9,222
6,403
12,639
9,117
12,463
8,740
11,331
7,568
3,949
6,897
3,612
3,969
4,044
6,098
7,109
7,531
6,780
7,201
4,958
3,187
3,126
2,816
5,435
4,929
5,226
5,145
8,364
23,214
22,572
23,769
6,002
1,772
4,253
2,377
1,863
1,461
1,732
1,7321,4611,8632,3774,2531,7726,00223,76922,57223,2148,3645,1455,2264,9295,4352,8163,1263,1874,9587,2016,7807,5317,1096,0984,0443,9693,6126,8973,9497,56811,3318,74012,4639,11712,6396,4039,22211,68713,6947,5849,1967,8369,5866,8868,69910,92613,32515,21310,29011,71513,62215,10216,98718,92419,08020,79322,93722,0375,4655,92012,30221,59213,51410,8847,0976,7004,7786,8167,9106,5675,1625,3968,1703,3042,7682,4381,93630,64310,30110,9001,6230002,702
       Short-term Investments 
0
0
0
0
0
0
0
0
18,575
20,410
23,987
27,520
24,082
26,972
29,502
31,570
32,411
31,791
32,316
28,803
22,622
15,698
9,258
25
7,495
9,995
9,990
9,995
7,495
4,995
2,500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,966
19,055
16,946
9,403
16,768
16,177
16,265
16,26516,17716,7689,40316,94619,05516,966000000000000000000000000000000000000000000000002,5004,9957,4959,9959,9909,9957,495259,25815,69822,62228,80332,31631,79132,41131,57029,50226,97224,08227,52023,98720,41018,57500000000
       Net Receivables 
0
0
0
0
1,852
1,972
2,769
2,928
3,127
3,528
3,724
4,161
4,543
5,577
6,320
7,785
7,699
6,715
6,247
6,342
5,732
5,323
5,029
3,690
3,661
3,565
3,470
3,449
3,326
3,048
2,758
2,326
1,593
1,254
1,057
993
910
870
519
611
566
533
562
619
391
531
533
612
580
922
589
902
743
491
329
571
739
950
985
423
1,049
1,589
1,114
1,616
1,083
972
727
1,698
488
567
589
633
334
478
457
640
311
683
548
702
647
576
747
614
519
5196147475766477025486833116404574783346335895674881,6987279721,0831,6161,1141,5891,0494239859507395713294917439025899225806125335313916195625335666115198709109931,0571,2541,5932,3262,7583,0483,3263,4493,4703,5653,6613,6905,0295,3235,7326,3426,2476,7157,6997,7856,3205,5774,5434,1613,7243,5283,1272,9282,7691,9721,8520000
       Other Current Assets 
323
0
0
0
116
110
1,345
126
141
154
173
196
223
249
281
317
370
379
423
449
464
427
421
487
578
735
555
635
537
26,427
538
843
685
648
470
632
531
354
1,973
546
1,874
414
1,629
1,660
1,371
476
350
441
1,868
1,820
2,360
879
2,684
2,724
1,071
1,291
3,638
1,420
4,182
4,251
5,060
3,736
692
828
4,851
4,429
3,891
672
2,305
340
188
2,361
1,864
363
181
710
1,616
423
242
846
2,907
2,833
2,662
3,068
779
7793,0682,6622,8332,9078462424231,6167101813631,8642,3611883402,3056723,8914,4294,8518286923,7365,0604,2514,1821,4203,6381,2911,0712,7242,6848792,3601,8201,8684413504761,3711,6601,6294141,8745461,97335453163247064868584353826,4275376355557355784874214274644494233793703172812492231961731541411261,345110116000323
   > Long-term Assets 
0
0
0
0
2,332
2,446
2,501
2,716
12,217
9,738
5,707
2,461
2,581
2,668
2,735
2,794
2,922
2,864
2,852
2,778
14,350
9,979
8,266
3,621
1,736
2,067
1,859
1,763
1,711
1,612
1,503
1,391
1,389
1,284
871
807
725
677
385
329
304
263
234
207
230
199
181
199
312
908
1,034
959
887
844
799
756
697
626
589
552
496
475
469
467
482
2,277
1,965
1,871
1,463
1,329
1,202
1,050
905
755
738
733
700
661
630
600
563
524
484
581
570
5705814845245636006306617007337387559051,0501,2021,3291,4631,8711,9652,2774824674694754965525896266977567998448879591,0349083121991811992302072342633043293856777258078711,2841,3891,3911,5031,6121,7111,7631,8592,0671,7363,6218,2669,97914,3502,7782,8522,8642,9222,7942,7352,6682,5812,4615,7079,73812,2172,7162,5012,4462,3320000
       Property Plant Equipment 
350
0
0
0
339
455
499
697
679
675
794
790
876
936
974
999
1,115
1,081
1,095
1,059
2,974
2,811
2,739
869
1,073
1,047
974
918
907
851
779
698
732
660
626
566
484
437
376
312
294
259
231
205
229
198
180
198
312
540
810
745
684
651
615
582
533
471
444
417
441
432
431
380
407
2,247
1,935
1,841
1,433
1,299
1,173
1,021
876
727
709
704
674
635
604
574
536
497
458
555
544
5445554584975365746046356747047097278761,0211,1731,2991,4331,8411,9352,2474073804314324414174444715335826156516847458105403121981801982292052312592943123764374845666266607326987798519079189741,0471,0738692,7392,8112,9741,0591,0951,0811,115999974936876790794675679697499455339000350
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,833
5,833
4,463
1,838
0
333
315
298
280
263
245
228
210
193
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000019321022824526328029831533301,8384,4635,8335,83300000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,800
4,708
4,463
1,838
0
333
315
298
280
761
245
228
210
193
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000019321022824576128029831533301,8384,4634,7082,80000000000000000000000
       Long-term Assets Other 
0
0
0
0
1,993
1,991
2,002
2,019
-9,485,620
-6,997,822
-2,829,792
1,671
1,706
1,732
1,761
1,794
1,807
1,783
1,756
1,719
2,743
2,460
1,065
914
663
687
570
547
524
499
479
465
447
431
245
241
242
240
9
16
10
4
3
2
1
1
1
1
1
368
224
214
204
194
184
174
164
154
145
135
55
43
38
86
75
30
30
30
30
30
29
29
29
28
28
29
26
26
26
26
26
26
26
26
26
2626262626262626262928282929293030303030758638435513514515416417418419420421422436811111234101692402422412454314474654794995245475706876639141,0652,4602,7431,7191,7561,7831,8071,7941,7611,7321,7061,671-2,829,792-6,997,822-9,485,6202,0192,0021,9911,9930000
> Total Liabilities 
1,297
0
0
0
52,720
71,690
74,138
3,275
3,896
4,977
5,267
5,536
6,649
6,898
7,269
8,758
12,298
11,526
10,333
11,076
9,645
9,416
7,827
7,571
8,546
5,153
5,265
27,486
4,857
4,572
4,081
3,905
2,867
2,649
2,341
3,029
3,132
2,461
2,572
2,613
2,077
1,996
5,008
3,896
3,602
3,409
7,751
7,368
8,015
7,449
4,413
4,438
3,472
3,456
3,015
3,639
3,323
3,237
3,711
4,255
4,582
3,486
4,087
4,179
6,015
5,714
5,957
4,933
4,363
3,692
3,117
2,968
2,747
2,460
1,934
2,066
1,672
2,010
1,846
2,066
1,314
1,597
1,362
1,383
1,333
1,3331,3831,3621,5971,3142,0661,8462,0101,6722,0661,9342,4602,7472,9683,1173,6924,3634,9335,9575,7146,0154,1794,0873,4864,5824,2553,7113,2373,3233,6393,0153,4563,4724,4384,4137,4498,0157,3687,7513,4093,6023,8965,0081,9962,0772,6132,5722,4613,1323,0292,3412,6492,8673,9054,0814,5724,85727,4865,2655,1538,5467,5717,8279,4169,64511,07610,33311,52612,2988,7587,2696,8986,6495,5365,2674,9773,8963,27574,13871,69052,7200001,297
   > Total Current Liabilities 
992
0
0
0
2,132
2,455
4,296
2,716
3,235
4,258
4,467
4,633
5,633
5,794
6,048
7,403
10,890
10,215
9,102
10,004
8,720
8,635
7,196
7,049
8,010
4,634
4,798
5,167
4,482
4,249
3,814
3,675
2,657
2,494
2,230
2,940
3,013
2,349
2,420
2,528
2,006
1,940
2,112
1,895
1,648
1,970
2,373
2,555
2,698
3,319
3,361
3,538
3,191
3,270
2,906
3,587
3,318
3,065
3,670
4,255
4,582
3,486
4,087
4,179
6,015
4,503
4,840
3,915
3,447
2,882
2,419
2,386
2,285
2,088
1,583
1,736
1,366
1,727
1,588
1,832
1,106
1,417
1,210
1,260
1,241
1,2411,2601,2101,4171,1061,8321,5881,7271,3661,7361,5832,0882,2852,3862,4192,8823,4473,9154,8404,5036,0154,1794,0873,4864,5824,2553,6703,0653,3183,5872,9063,2703,1913,5383,3613,3192,6982,5552,3731,9701,6481,8952,1121,9402,0062,5282,4202,3493,0132,9402,2302,4942,6573,6753,8144,2494,4825,1674,7984,6348,0107,0497,1968,6358,72010,0049,10210,21510,8907,4036,0485,7945,6334,6334,4674,2583,2352,7164,2962,4552,132000992
       Short-term Debt 
0
0
0
0
515
851
883
0
0
0
0
0
0
0
0
0
0
0
13
13
13
13
13
13
30
24
26
28
30
33
35
38
19
19
19
20
20
21
21
21
18
13
7
35
33
32
33
54
60
72
-876
149
57
40
56
48
48
0
0
0
0
0
0
0
0
580
583
586
589
591
594
597
600
566
458
345
229
148
148
148
148
148
148
148
148
148148148148148148148148229345458566600597594591589586583580000000004848564057149-876726054333233357131821212120201919193835333028262430131313131313000000000008838515150000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
580
583
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000058358000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
105
0
0
0
434
275
756
978
899
1,506
1,494
1,268
1,699
1,438
1,599
1,864
2,767
2,085
2,908
2,497
2,628
2,555
1,549
1,540
201
1,079
1,316
1,260
1,087
1,389
722
648
259
230
175
461
629
400
465
405
257
226
208
263
323
578
535
523
523
917
876
946
1,060
1,381
645
714
734
404
758
725
733
384
800
1,151
1,298
558
1,017
639
726
623
191
192
142
381
290
317
284
361
401
539
368
400
181
225
216
2162251814003685394013612843172903811421921916237266391,0175581,2981,1518003847337257584047347146451,3811,0609468769175235235355783232632082262574054654006294611752302596487221,3891,0871,2601,3161,0792011,5401,5492,5552,6282,4972,9082,0852,7671,8641,5991,4381,6991,2681,4941,506899978756275434000105
       Other Current Liabilities 
880
0
0
0
937
1,084
2,380
1,408
1,937
2,288
2,427
2,720
3,174
3,482
3,437
4,373
6,736
6,710
4,652
5,912
4,436
4,392
3,946
3,760
6,722
2,585
2,620
3,121
2,665
2,159
2,476
2,468
1,911
1,871
1,722
2,214
2,151
1,786
1,753
1,915
1,596
1,577
1,778
1,484
1,224
1,296
1,756
1,939
2,090
1,994
2,749
1,750
1,847
1,845
1,793
2,195
1,908
1,916
2,252
2,604
3,028
3,102
3,287
3,027
2,761
3,183
3,240
2,691
2,133
1,668
1,634
1,597
1,543
1,140
708
962
853
1,218
1,039
1,145
590
868
880
887
877
8778878808685901,1451,0391,2188539627081,1401,5431,5971,6341,6682,1332,6913,2403,1832,7613,0273,2873,1023,0282,6042,2521,9161,9082,1951,7931,8451,8471,7502,7491,9942,0901,9391,7561,2961,2241,4841,7781,5771,5961,9151,7531,7862,1512,2141,7221,8711,9112,4682,4762,1592,6653,1212,6202,5856,7223,7603,9464,3924,4365,9124,6526,7106,7364,3733,4373,4823,1742,7202,4272,2881,9371,4082,3801,084937000880
   > Long-term Liabilities 
0
0
0
0
50,588
69,235
69,842
559
661
719
800
902
1,016
1,104
1,221
1,355
1,408
1,311
1,230
1,072
925
780
630
521
535
519
467
22,319
375
323
267
230
210
155
112
89
119
112
153
85
71
56
2,896
2,001
1,954
1,439
5,379
4,813
5,317
4,130
1,052
901
280
186
109
52
5
172
41
0
0
0
0
0
0
1,211
1,117
1,019
917
810
698
582
461
372
351
329
307
283
259
234
208
180
152
123
92
921231521802082342592833073293513724615826988109171,0191,1171,211000000411725521091862809011,0524,1305,3174,8135,3791,4391,9542,0012,8965671851531121198911215521023026732337522,3194675195355216307809251,0721,2301,3111,4081,3551,2211,1041,01690280071966155969,84269,23550,5880000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27
23
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000023270000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-515
-851
-883
0
0
0
0
0
0
0
0
0
0
0
-13
-13
-13
-13
-13
-13
-30
-24
-26
-28
-30
-33
-35
-38
-19
-19
7
3
-20
-21
-21
-21
-18
-13
-7
-35
-33
-32
-33
-54
-60
-72
876
-149
-57
-40
-56
-48
-48
0
0
0
0
0
0
0
0
1,211
1,117
1,019
917
810
698
582
461
372
351
329
307
283
259
234
59
32
4
-26
92
92-26432592342592833073293513724615826988109171,0191,1171,21100000000-48-48-56-40-57-149876-72-60-54-33-32-33-35-7-13-18-21-21-21-2037-19-19-38-35-33-30-28-26-24-30-13-13-13-13-13-1300000000000-883-851-5150000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,939
1,424
5,368
4,803
5,307
4,121
1,042
890
280
186
109
52
5
0
0
0
0
0
0
0
0
1,211
1,117
1,019
917
810
698
582
461
372
351
0
0
0
0
0
0
0
0
0
0
00000000003513724615826988109171,0191,1171,211000000005521091862808901,0424,1215,3074,8035,3681,4241,93900000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
85
66
101
99
145
0
0
0
0
0
15
15
11
10
10
9
10
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000101091010111515000001459910166850000000000000000000000000000000000
> Total Stockholder Equity
5,756
0
0
0
-45,502
-54,611
-55,771
34,769
34,056
33,566
33,768
34,747
36,248
37,691
40,439
43,834
43,409
42,617
42,340
39,644
46,730
38,011
33,903
26,574
22,833
22,250
21,131
15,287
35,710
31,494
27,189
24,080
20,199
17,647
15,419
13,121
11,089
15,870
13,110
10,587
8,800
6,895
6,441
5,807
7,195
6,047
7,610
6,201
3,387
1,682
11,620
8,490
12,563
8,852
11,563
7,710
4,961
7,852
4,672
4,518
5,017
6,823
7,722
8,860
6,098
8,192
4,858
3,574
2,530
2,514
5,489
5,372
5,248
5,261
8,835
24,228
23,216
24,238
23,411
21,966
23,356
22,013
21,411
19,904
20,091
20,09119,90421,41122,01323,35621,96623,41124,23823,21624,2288,8355,2615,2485,3725,4892,5142,5303,5744,8588,1926,0988,8607,7226,8235,0174,5184,6727,8524,9617,71011,5638,85212,5638,49011,6201,6823,3876,2017,6106,0477,1955,8076,4416,8958,80010,58713,11015,87011,08913,12115,41917,64720,19924,08027,18931,49435,71015,28721,13122,25022,83326,57433,90338,01146,73039,64442,34042,61743,40943,83440,43937,69136,24834,74733,76833,56634,05634,769-55,771-54,611-45,5020005,756
   Common Stock
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
0
0
1
1
1
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
1
1
1
0
0
0
1
1
1
1
1
1
1
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
0
0111111111100000011111110001110001111111100001110022222222111111111111111111110000000
   Retained Earnings Total Equity0000000000-197,473-196,942-196,882-196,600-196,300-195,400-194,790-193,700-192,328-189,000-191,017-188,214-189,300-189,874-191,300-188,458-184,900-181,711-178,479-175,665-171,756-167,661-163,566-160,857-157,653-156,450-154,378-151,469-150,007-147,837-146,61200000000-126,169-123,7380000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-601
-637
-2,979
-824
-745
-669
-597
-494
-426
-344
-280
-187
-111
-57
-29
-2,012
-1,442
-2,435
-2,435
-2,435
-2,870
-2,870
0
0
-3,379
-3,379
0
0
-3,771
-3,771
0
0
-4,130
0
0
0
-4,217
0
0
0
-2,951
0
0
0
-2,516
0
0
0
-2,316
0
0
0
-2,568
0
0
0
-1,133
0
0
0
-1,160
0
0
0
-1,231
0
0
0
0
0
0
0
0
0
0
0
0
66
169
207
240
24020716966000000000000-1,231000-1,160000-1,133000-2,568000-2,316000-2,516000-2,951000-4,217000-4,13000-3,771-3,77100-3,379-3,37900-2,870-2,870-2,435-2,435-2,435-1,442-2,012-29-57-111-187-280-344-426-494-597-669-745-824-2,979-637-6010000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
139,154
139,289
0
0
0
0
0
0
0
0
153,806
153,883
157,617
157,669
157,765
158,130
169,272
169,345
176,128
176,513
183,319
183,374
183,439
189,563
189,621
192,975
196,355
196,696
197,021
197,073
197,114
197,158
197,185
197,305
197,320
197,961
201,787
201,927
202,129
202,202
206,308
0
0
0
0
0
0
0
0
0
0
0000000000206,308202,202202,129201,927201,787197,961197,320197,305197,185197,158197,114197,073197,021196,696196,355192,975189,621189,563183,439183,374183,319176,513176,128169,345169,272158,130157,765157,669157,617153,883153,80600000000139,289139,1540000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
547
557
-447,622
-37,951,443
-37,860,250
92,309
92,479
92,585
93,212
94,426
95,580
96,468
97,205
97,738
98,723
101,581
110,236
113,318
114,138
114,661
112,627
113,260
113,942
117,361
140,800
137,886
138,183
138,474
142,572
138,946
139,154
139,289
143,804
147,206
147,219
147,305
151,610
147,742
148,632
148,715
156,758
153,883
157,617
157,669
160,281
158,130
169,272
169,345
178,444
176,513
183,319
183,374
186,006
189,563
189,621
192,975
197,489
196,696
197,021
197,073
198,274
197,158
197,185
197,305
198,551
197,961
201,787
201,927
202,129
202,202
206,308
222,388
222,378
224,359
224,692
224,854
226,935
227,100
227,933
228,156
229,960
229,960228,156227,933227,100226,935224,854224,692224,359222,378222,388206,308202,202202,129201,927201,787197,961198,551197,305197,185197,158198,274197,073197,021196,696197,489192,975189,621189,563186,006183,374183,319176,513178,444169,345169,272158,130160,281157,669157,617153,883156,758148,715148,632147,742151,610147,305147,219147,206143,804139,289139,154138,946142,572138,474138,183137,886140,800117,361113,942113,260112,627114,661114,138113,318110,236101,58198,72397,73897,20596,46895,58094,42693,21292,58592,47992,309-37,860,250-37,951,443-447,6225575470000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue5,901
Cost of Revenue-1,954
Gross Profit3,9473,947
 
Operating Income (+$)
Gross Profit3,947
Operating Expense-11,099
Operating Income-7,152-7,152
 
Operating Expense (+$)
Research Development2,778
Selling General Administrative4,956
Selling And Marketing Expenses3,365
Operating Expense11,09911,099
 
Net Interest Income (+$)
Interest Income412
Interest Expense-0
Other Finance Cost-0
Net Interest Income412
 
Pretax Income (+$)
Operating Income-7,152
Net Interest Income412
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,529-7,774
EBIT - interestExpense = -7,152
-6,529
-6,529
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-7,152-6,529
Earnings Before Interest and Taxes (EBITDA)-7,096
 
After tax Income (+$)
Income Before Tax-6,529
Tax Provision-0
Net Income From Continuing Ops-5,572-6,529
Net Income-6,529
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses13,053
Total Other Income/Expenses Net622-412
 

Technical Analysis of Neurometrix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Neurometrix. The general trend of Neurometrix is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Neurometrix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of NeuroMetrix Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4.808 < 4.96 < 4.96.

The bearish price targets are: 4.4 > 4.2783 > 3.51.

Tweet this
NeuroMetrix Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of NeuroMetrix Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

NeuroMetrix Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of NeuroMetrix Inc. The current macd is 0.13263647.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Neurometrix price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Neurometrix. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Neurometrix price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
NeuroMetrix Inc Daily Moving Average Convergence/Divergence (MACD) ChartNeuroMetrix Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of NeuroMetrix Inc. The current adx is 23.91.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Neurometrix shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
NeuroMetrix Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of NeuroMetrix Inc. The current sar is 3.70070447.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
NeuroMetrix Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of NeuroMetrix Inc. The current rsi is 62.20. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
NeuroMetrix Inc Daily Relative Strength Index (RSI) ChartNeuroMetrix Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of NeuroMetrix Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Neurometrix price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
NeuroMetrix Inc Daily Stochastic Oscillator ChartNeuroMetrix Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of NeuroMetrix Inc. The current cci is 117.37.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
NeuroMetrix Inc Daily Commodity Channel Index (CCI) ChartNeuroMetrix Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of NeuroMetrix Inc. The current cmo is 30.49.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
NeuroMetrix Inc Daily Chande Momentum Oscillator (CMO) ChartNeuroMetrix Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of NeuroMetrix Inc. The current willr is -23.72881356.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Neurometrix is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
NeuroMetrix Inc Daily Williams %R ChartNeuroMetrix Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of NeuroMetrix Inc.

NeuroMetrix Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of NeuroMetrix Inc. The current atr is 0.26422164.

NeuroMetrix Inc Daily Average True Range (ATR) ChartNeuroMetrix Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of NeuroMetrix Inc. The current obv is 9,129,444.

NeuroMetrix Inc Daily On-Balance Volume (OBV) ChartNeuroMetrix Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of NeuroMetrix Inc. The current mfi is 88.90.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
NeuroMetrix Inc Daily Money Flow Index (MFI) ChartNeuroMetrix Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for NeuroMetrix Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

NeuroMetrix Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of NeuroMetrix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.199
Ma 20Greater thanMa 503.953
Ma 50Greater thanMa 1003.839
Ma 100Greater thanMa 2003.584
OpenGreater thanClose4.415
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Neurometrix with someone you think should read this too:
  • Are you bullish or bearish on Neurometrix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Neurometrix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about NeuroMetrix Inc

I send you an email if I find something interesting about NeuroMetrix Inc.


Comments

How you think about this?

Leave a comment

Stay informed about NeuroMetrix Inc.

Receive notifications about NeuroMetrix Inc in your mailbox!